News
A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...
The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
9d
MedPage Today on MSNPrimary Surgery for Ovarian Cancer Scores a Win -- Sort OfPrespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...
Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...
The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...
The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...
IPV Vaccines Market Set to Expand at CAGR of 8.7% Through 2032 | Sanofi Pasteur, GlaxoSmithKline plc
The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results